Liposomal bupivacaine versus ropivacaine for surgical site infiltration in lumbar fusion: a prospective randomized controlled trial
Feng Yue, Wenwen Zhai, Yanhan Lyu, Qiang Qi, Min Li · 2026
Read Liposomal bupivacaine versus ropivacaine for surgical site infiltration in lumbar fusion: a prospective randomized controlled trial by Feng Yue, Wenwen Zhai, Yanhan Lyu, Qiang Qi, Min Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13410536.txt.
Description
Feng Yue and co-workers run in 2026 a trial of two numbing drugs placed in the wound during lower back fusion surgery. Good pain control after spine fusion is hard, and heavy opioid use brings its own harms. One drug came in a slow-release fat bubble form meant to work for days.
The trial enrolled 202 patients having one- or two-level fusion, split evenly between the slow-release mix and standard ropivacaine. Over three days, the slow-release group used notably less opioid pain medicine, about a fifth less in relative terms. Pain scores at rest and in motion also ran lower. Rescue pain relief, side effects, and recovery of function did not differ clearly between groups.
Catalog record
| CREATOR | Feng Yue, Wenwen Zhai, Yanhan Lyu, Qiang Qi, Min Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |